Posted on December 23, 201912/23/19
ICER’s Unsupported Price Increase Assessment
Posted on December 16, 201912/16/19
U.S. physicians disagree with Germany’s determinations of the value of diabetes medicines
Posted on December 10, 201912/10/19
Rethinking Patient Centricity in a Dynamic Market Access Driven Ecosystem
Posted on December 10, 201912/10/19
Strategies to Ensure Market Success of a Rare Disease Product Launch
Posted on December 9, 201912/9/19
How to Demonstrate Value to Providers, Payers & Patients
Posted on December 4, 201912/4/19
More Data, More Problems, More Potential
Posted on November 30, 201911/30/19
What’s next for ICER? Pharmaceutical pricing watchdog to venture beyond the pill.
Posted on November 25, 201911/25/19
Developing an Optimal Hub to Ensure Product Access
Posted on November 22, 201911/22/19
WHAT IF… We Broke the Silos Throughout Pre- to Post-Commercialization?
Posted on November 22, 201911/22/19